Meningococcal polyvalent vaccine is routinely recommended to:
Ans. b. All healthy children between 5-7 years of age (Ref: Park 23/e p166, 22/e p157)'Quadrivalent (polyvalent) vaccines are administered as a single dose to individuals aged >_ 2 years.'- Park 22/e p157Meningococcal VaccinesPolysaccharide VaccinesConjugate Vaccines* Available against Meningococci of serogroup A, C, W135, and Y.* Types:- Bivalent (A, C)- Trivalent (A, C, W135)- Quadrivalent (A, C, W135, Y)* Polysaccharide vaccines are administered as a single dose to persons > 2 years old* Most of these vaccines are given subcutaneously* MC reaction is 1-2 days of pain and redness at the site of injection in 4-56% of recipients* More immunogenic, induce immunogenic memory* Types:- Monovalent (A or C)- Quadrivalent (A, C, W135, Y)* Given as IM injection, preferably in deltoid muscle (or in the anterolateral aspect of thigh in children <12 months)* Monovalent Men A conjugate vaccine should be given as a single dose to individuals 1-29 years of age* For Monovalent Men C conjugate vaccine, one single IM dose is recommended for children aged > 12 months, teenagers and adults. Children 2-11 months of age require 2 doses administration at an interval of at least 2 months and a booster about 1 year thereafter.* Quadrivalent vaccines are administered as a single dose to individuals aged > 2 years.
Adolescents young males
All healthy children between 5-7 years of age
More than 50 years of age diabetic patients on regular insulin
40 years old paramedical staff working in laboratory
Meningococcal Meningitis